Concepedia

Publication | Open Access

First-line bevacizumab combined with reduced dose interferon-α2a is active in patients with metastatic renal cell carcinoma

DOIFull Paper Access

103

Citations

31

References

2008

Year

Bohuslav Melichar, P. Koralewski, Alain Ravaud, A Płużańska, Sergio Bracarda, Cezary Szczylik, Christine Chevreau, M. Filipek, R. Delva, Emmanuel Sevin,
Annals of Oncology

References

YearCitations

Page 1